Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.

Hwang JP, Lim I, Kong CB, Jeon DG, Byun BH, Kim BI, Choi CW, Lim SM.

PLoS One. 2016 Apr 21;11(4):e0153281. doi: 10.1371/journal.pone.0153281. eCollection 2016.

2.

Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.

Hwang JP, Lim I, Byun BH, Kim BI, Choi CW, Lim SM.

Nucl Med Commun. 2016 Dec;37(12):1267-1272.

PMID:
27482643
3.

Prognostic value of SUVmax measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Pancreatic Cancer.

Hwang JP, Lim I, Chang KJ, Kim BI, Choi CW, Lim SM.

Nucl Med Mol Imaging. 2012 Sep;46(3):207-14. doi: 10.1007/s13139-012-0151-y. Epub 2012 Jun 30.

4.

Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma.

Raciborska A, Bilska K, Drabko K, Michalak E, Chaber R, Pogorzała M, Połczyńska K, Sobol G, Wieczorek M, Muszyńska-Rosłan K, Rychlowska-Pruszyńska M, Rodriguez-Galindo C, Dziuk M.

Clin Transl Oncol. 2016 Feb;18(2):189-95. doi: 10.1007/s12094-015-1351-6. Epub 2015 Aug 7.

PMID:
26250765
5.

Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma.

Andersen KF, Fuglo HM, Rasmussen SH, Petersen MM, Loft A.

Medicine (Baltimore). 2015 Dec;94(51):e2319. doi: 10.1097/MD.0000000000002319.

6.

[Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].

Ding CY, Guo Z, Sun J, Yang WP, Li TR.

Zhonghua Zhong Liu Za Zhi. 2018 Jul 23;40(7):528-533. doi: 10.3760/cma.j.issn.0253-3766.2018.07.009. Chinese.

PMID:
30060362
7.

Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.

Cacicedo J, Fernandez I, Del Hoyo O, Navarro A, Gomez-Iturriaga A, Pijoan JI, Martinez-Indart L, Escudero J, Gomez-Suarez J, de Zarate RO, Perez JF, Bilbao P, Rades D.

Clin Transl Oncol. 2017 Nov;19(11):1337-1349. doi: 10.1007/s12094-017-1674-6. Epub 2017 May 24.

PMID:
28540535
8.

Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.

Namura K, Minamimoto R, Yao M, Makiyama K, Murakami T, Sano F, Hayashi N, Tateishi U, Ishigaki H, Kishida T, Miura T, Kobayashi K, Noguchi S, Inoue T, Kubota Y, Nakaigawa N.

BMC Cancer. 2010 Dec 3;10:667. doi: 10.1186/1471-2407-10-667.

9.

Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters.

Hong SP, Lee SE, Choi YL, Seo SW, Sung KS, Koo HH, Choi JY.

Skeletal Radiol. 2014 May;43(5):641-8. doi: 10.1007/s00256-014-1832-7. Epub 2014 Feb 15.

PMID:
24531303
10.

The prognostic value of SUVmax measuring on primary lesion and ALN by 18F-FDG PET or PET/CT in patients with breast cancer.

Diao W, Tian F, Jia Z.

Eur J Radiol. 2018 Aug;105:1-7. doi: 10.1016/j.ejrad.2018.05.014. Epub 2018 May 17. Review.

PMID:
30017264
11.

[Prognostic value of preoperative positron emission tomography-computed tomography in surgically resected gastric cancer].

Kim KS, Choi SR, Park IC, Koo TH, Kim JM.

Korean J Gastroenterol. 2014 Jun;63(6):348-53. Korean.

12.

The preoperative SUVmax for (18)F-FDG uptake predicts survival in patients with colorectal cancer.

Shi D, Cai G, Peng J, Li D, Li X, Xu Y, Cai S.

BMC Cancer. 2015 Dec 21;15:991. doi: 10.1186/s12885-015-1991-5.

13.

The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.

Palmerini E, Colangeli M, Nanni C, Fanti S, Marchesi E, Paioli A, Picci P, Cambioli S, Donati D, Cevolani L, De Paolis M, Gambarotti M, Ferrari S.

Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):215-223. doi: 10.1007/s00259-016-3509-z. Epub 2016 Sep 20.

14.

Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.

Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y.

Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.

PMID:
22999369
15.

Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.

Song BI, Kim HW, Won KS, Ryu SW, Sohn SS, Kang YN.

Medicine (Baltimore). 2015 Jul;94(26):e1037. doi: 10.1097/MD.0000000000001037.

16.

Large cell neuroendocrine carcinoma of the lung: CT and FDG PET findings.

Lee KW, Lee Y, Oh SW, Jin KN, Goo JM.

Eur J Radiol. 2015 Nov;84(11):2332-8. doi: 10.1016/j.ejrad.2015.07.033. Epub 2015 Jul 30.

PMID:
26279139
17.

Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.

Andersen KF, Fuglo HM, Rasmussen SH, Petersen MM, Loft A.

Medicine (Baltimore). 2015 Jul;94(28):e1142. doi: 10.1097/MD.0000000000001142.

18.

Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?

Kasalak Ö, Glaudemans AWJM, Overbosch J, Jutte PC, Kwee TC.

Skeletal Radiol. 2018 Mar;47(3):363-367. doi: 10.1007/s00256-017-2807-2. Epub 2017 Nov 9.

19.

Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer.

Suzuki H, Kato K, Fujimoto Y, Itoh Y, Hiramatsu M, Naganawa S, Hasegawa Y, Nakashima T.

Ann Nucl Med. 2014 May;28(4):356-62. doi: 10.1007/s12149-014-0817-x. Epub 2014 Feb 11.

PMID:
24515867
20.

Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.

Sharma P, Khangembam BC, Suman KC, Singh H, Rastogi S, Khan SA, Bakhshi S, Thulkar S, Bal C, Malhotra A, Kumar R.

Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1036-43. doi: 10.1007/s00259-013-2388-9. Epub 2013 Apr 5.

PMID:
23558689

Supplemental Content

Support Center